• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者的长期健康改善与经济表现

Long-Term Health Improvements and Economic Performance Among Individuals With Diabetes.

作者信息

Chapel Jack M, Goldman Dana P, Kahn Matthew E, Tysinger Bryan

机构信息

Leonard D. Schaeffer Center for Health Policy and Economics, Los Angeles, California.

Sol Price School of Public Policy, University of Southern California, Los Angeles.

出版信息

JAMA Health Forum. 2025 May 2;6(5):e250756. doi: 10.1001/jamahealthforum.2025.0756.

DOI:10.1001/jamahealthforum.2025.0756
PMID:40377930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12084845/
Abstract

IMPORTANCE

Advances in diabetes detection and treatment have mitigated the risks of serious complications and death, but little is known about whether economic outcomes for people with diabetes have similarly improved.

OBJECTIVE

To assess whether associations between diagnosed diabetes and labor market outcomes have changed over time.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study analyzed data from the National Health Interview Survey from 1998 to 2018. The sample was nationally representative of the US population aged 40 to 64 years. Average marginal effects, the regression-adjusted difference in probability of outcomes between people with and without diabetes, pooled by 3-year periods (1998-2000 to 2016-2018), were estimated with controls for demographics, education, and comorbid health risks. Behavioral Risk Factor Surveillance (BRFSS) data from 1993 to 2023 were included in robustness analyses. Data were analyzed from September 2023 to November 2024.

EXPOSURE

Diagnosed diabetes, defined based on respondents' self-report that they have ever been diagnosed by a medical professional.

MAIN OUTCOMES AND MEASURES

The main outcomes were labor force participation and any Supplemental Security Income or Social Security Disability Insurance income receipt. Secondary outcomes included reporting health limitations for any activities, health limitations for work, any nights in hospital, and receiving health care 10 or more times in the past year.

RESULTS

The study included 249 712 individuals, 25 177 with diabetes. The weighted population was 50% female, 12% Hispanic, 11% non-Hispanic Black, 72% non-Hispanic White, and 5% multiracial or other race (Alaska Native or American Indian, Asian, or nonspecified). In the weighted population from 1998 to 2000, 46% of people with diabetes were 55 years and older, while 27% of people without diabetes were 55 years and older. In the weighted population from 2016 to 2018, 56% of people with diabetes were 55 years and older, while 38% of people without diabetes were 55 years and older. The average marginal effect of diabetes on probability of labor force participation was -10.9 percentage points (95% CI, -13.0 to -8.9) from 1998 to 2000 and -11.0 percentage points (95% CI, -13.0 to -9.1) from 2016 to 2018; for people who received Supplemental Security Income or Social Security Disability Insurance income, it was 4.4 percentage points (95% CI, 3.3-5.5) and 4.9 percentage points (95% CI, 3.7-6.0) from 1998 to 2000 and 2016 to 2018, respectively. During the same period, average marginal effects for all examined health outcomes significantly improved. Similar patterns were observed using BRFSS data, but with a slight improvement in labor force participation between 2017 to 2019 and 2021 to 2023.

CONCLUSIONS AND RELEVANCE

This cross-sectional study demonstrated that while people with diabetes experienced meaningful health improvements, they saw little progress in economic performance. Changing patient selection appears to play a role. Future research is needed to disentangle the paradox.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7841/12084845/379b8c1107d9/jamahealthforum-e250756-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7841/12084845/45a6fbd87657/jamahealthforum-e250756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7841/12084845/aef3e355f6be/jamahealthforum-e250756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7841/12084845/e7d4a10e3b39/jamahealthforum-e250756-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7841/12084845/379b8c1107d9/jamahealthforum-e250756-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7841/12084845/45a6fbd87657/jamahealthforum-e250756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7841/12084845/aef3e355f6be/jamahealthforum-e250756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7841/12084845/e7d4a10e3b39/jamahealthforum-e250756-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7841/12084845/379b8c1107d9/jamahealthforum-e250756-g004.jpg
摘要

重要性

糖尿病检测和治疗方面的进展降低了严重并发症和死亡风险,但对于糖尿病患者的经济状况是否同样得到改善,人们知之甚少。

目的

评估确诊糖尿病与劳动力市场结果之间的关联是否随时间发生了变化。

设计、背景和参与者:这项横断面研究分析了1998年至2018年美国国家健康访谈调查的数据。样本具有美国40至64岁人群的全国代表性。通过对人口统计学、教育程度和共病健康风险进行控制,估计了1998 - 2000年至2016 - 2018年这3年期间糖尿病患者和非糖尿病患者在结局概率上的回归调整平均边际效应。稳健性分析纳入了1993年至2023年的行为风险因素监测(BRFSS)数据。数据于2023年9月至2024年11月进行分析。

暴露因素

确诊糖尿病,根据受访者自我报告他们曾被医疗专业人员诊断来定义。

主要结局和衡量指标

主要结局是劳动力参与情况以及是否领取补充保障收入或社会保障残疾保险收入。次要结局包括报告任何活动存在健康限制、工作存在健康限制、住院过夜情况以及过去一年接受医疗护理10次或更多次。

结果

该研究纳入了249712人,其中25177人患有糖尿病。加权人群中50%为女性,12%为西班牙裔,11%为非西班牙裔黑人,72%为非西班牙裔白人,5%为多种族或其他种族(阿拉斯加原住民或美洲印第安人、亚洲人或未明确种族)。在1998年至2000年的加权人群中,46%的糖尿病患者年龄在55岁及以上,而无糖尿病患者中这一比例为27%。在2016年至2018年的加权人群中,56%的糖尿病患者年龄在55岁及以上,而无糖尿病患者中这一比例为38%。1998年至2000年糖尿病对劳动力参与概率的平均边际效应为 - 10.9个百分点(95%置信区间,- 13.0至- 8.9),2016年至2018年为 - 11.0个百分点(95%置信区间,- 13.0至- 9.1);对于领取补充保障收入或社会保障残疾保险收入的人,1998年至2000年为4.4个百分点(95%置信区间,3.3 - 5.5),2016年至2018年为4.9个百分点(95%置信区间,3.7 - 6.0)。在同一时期,所有检查的健康结局的平均边际效应均有显著改善。使用BRFSS数据也观察到了类似模式,但2017年至

相似文献

1
Long-Term Health Improvements and Economic Performance Among Individuals With Diabetes.糖尿病患者的长期健康改善与经济表现
JAMA Health Forum. 2025 May 2;6(5):e250756. doi: 10.1001/jamahealthforum.2025.0756.
2
Association of Work Requirements With Supplemental Nutrition Assistance Program Participation by Race/Ethnicity and Disability Status, 2013-2017.工作要求与 2013-2017 年补充营养援助计划参与度的关联:按种族/民族和残疾状况划分。
JAMA Netw Open. 2020 Jun 1;3(6):e205824. doi: 10.1001/jamanetworkopen.2020.5824.
3
Core state preconception health indicators - pregnancy risk assessment monitoring system and behavioral risk factor surveillance system, 2009.核心孕前健康指标 - 妊娠风险评估监测系统和行为危险因素监测系统,2009 年。
MMWR Surveill Summ. 2014 Apr 25;63(3):1-62.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.2019 年美国需要阿片类药物治疗的青少年和成年人中,阿片类药物使用障碍药物治疗的使用情况。
JAMA Netw Open. 2022 Mar 1;5(3):e223821. doi: 10.1001/jamanetworkopen.2022.3821.
6
Racial and Ethnic Disparities in Diabetes Screening Between Asian Americans and Other Adults: BRFSS 2012-2014.2012 - 2014年美国行为危险因素监测系统(BRFSS):亚裔美国人和其他成年人在糖尿病筛查方面的种族和族裔差异
J Gen Intern Med. 2017 Apr;32(4):423-429. doi: 10.1007/s11606-016-3913-x. Epub 2016 Nov 15.
7
Sociodemographic Characteristics of Persons With Diabetes糖尿病患者的社会人口学特征
8
Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.种族和民族的医疗保健机会和预防性健康筛查的变化。
JAMA Health Forum. 2024 Feb 2;5(2):e235058. doi: 10.1001/jamahealthforum.2023.5058.
9
Association Between Supplemental Nutrition Assistance Program Participation and Cost-Related Medication Nonadherence Among Older Adults With Diabetes.补充营养援助计划参与度与老年糖尿病患者药物费用相关不依从性的相关性。
JAMA Intern Med. 2019 Jan 1;179(1):63-70. doi: 10.1001/jamainternmed.2018.5011.
10
State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.特定慢性病相关特征的州患病率——行为危险因素监测系统,2001年
MMWR Surveill Summ. 2003 Aug 22;52(8):1-80.

本文引用的文献

1
The education-health gradient: Revisiting the role of socio-emotional skills.教育-健康梯度:重新审视社会情感技能的作用。
J Health Econ. 2024 Sep;97:102911. doi: 10.1016/j.jhealeco.2024.102911. Epub 2024 Jun 19.
2
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
3
Economic Costs of Diabetes in the U.S. in 2022.2022 年美国糖尿病的经济成本。
Diabetes Care. 2024 Jan 1;47(1):26-43. doi: 10.2337/dci23-0085.
4
Mortality in the United States, 2021.2021年美国的死亡率
NCHS Data Brief. 2022 Dec(456):1-8.
5
Undiagnosed Diabetes in U.S. Adults: Prevalence and Trends.美国成年人未确诊的糖尿病:患病率和趋势。
Diabetes Care. 2022 Sep 1;45(9):1994-2002. doi: 10.2337/dc22-0242.
6
Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018.1999 - 2018年美国成年人糖尿病患病率及糖尿病危险因素控制趋势
JAMA. 2021 Jun 25;326(8):1-13. doi: 10.1001/jama.2021.9883.
7
Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018.美国成年人糖尿病治疗和控制的趋势,1999-2018 年。
N Engl J Med. 2021 Jun 10;384(23):2219-2228. doi: 10.1056/NEJMsa2032271.
8
Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes.美国新诊断 2 型糖尿病成年人并发症 30 年趋势。
Diabetes Care. 2021 Mar;44(3):699-706. doi: 10.2337/dc20-2304. Epub 2021 Jan 8.
9
Prediabetes and What It Means: The Epidemiological Evidence.糖尿病前期及其意义:流行病学证据。
Annu Rev Public Health. 2021 Apr 1;42:59-77. doi: 10.1146/annurev-publhealth-090419-102644. Epub 2021 Dec 23.
10
New hypertension and diabetes diagnoses following the Affordable Care Act Medicaid expansion.平价医疗法案扩大医疗补助计划后新诊断的高血压和糖尿病。
Fam Med Community Health. 2020 Dec;8(4). doi: 10.1136/fmch-2020-000607.